Vitamin D Deficiency in Systemic Autoimmune Diseases: Clinical and Immunomodulatory Impact in Systemic Lupus Erythematosus and Rheumatoid Arthritis
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Vitamin D is a secosteroid hormone with well-established roles in calcium homeostasis and bone metabolism, as well as increasingly recognized immunomodulatory functions. Its synthesis begins in the skin following ultraviolet B exposure and requires sequential hepatic and renal hydroxylation to generate the active metabolite, 1,25-dihydroxyvitamin D. In systemic autoimmune diseases, this metabolic pathway is frequently disrupted, resulting in a high prevalence of vitamin D deficiency. Conditions such as systemic lupus erythematosus and rheumatoid arthritis consistently exhibit lower serum vitamin D levels compared with the general population, a finding influenced by chronic inflammation, photosensitivity, reduced sun exposure, glucocorticoid use, and genetic variability affecting vitamin D receptor function.At the immunological level, vitamin D exerts regulatory effects on both innate and adaptive immunity through its receptor, which is widely expressed in immune cells. It promotes immune tolerance by inducing a tolerogenic dendritic cell phenotype, enhancing regulatory T-cell differentiation, suppressing pro-inflammatory Th1 and Th17 responses, and modulating B-cell activation and autoantibody production. These mechanisms are particularly relevant in systemic lupus erythematosus, where vitamin D deficiency has been associated with increased disease activity, higher flare rates, fatigue, musculoskeletal involvement, renal disease, and cardiovascular risk, as well as elevated anti-double-stranded DNA antibody levels. Similarly, in rheumatoid arthritis, low vitamin D levels correlate with higher disease activity scores, pain severity, functional impairment, and increased risk of osteoporosis and fractures.Vitamin D supplementation has demonstrated immunomodulatory effects, including reductions in pro-inflammatory cytokines and potential improvements in disease activity and bone health. However, clinical trial outcomes remain inconsistent due to heterogeneous study designs, variable dosing regimens, and lack of baseline deficiency stratification. These limitations highlight the need for personalized supplementation strategies and further research to clarify the role of vitamin D as an adjunctive therapy in systemic autoimmune diseases.
Fields of Study & Subjects
Vitamin D Research Studies
Systemic Lupus Erythematosus Research
Systemic Sclerosis and Related Diseases
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 March 2026
- Language
- EN